EMEA-001418-PIP01-15-M01
Key facts
| Active substance |
Cabotegravir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0321/2017
|
| PIP number |
EMEA-001418-PIP01-15-M01
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
|
| Contact for public enquiries |
ViiV Healthcare UK Limited
Tel. +44 (0)208 990 3650 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|